Literature DB >> 11495415

Ovarian hyperstimulation after the sole use of a gonadotrophin-releasing hormone agonist (Nafarelin) as a complication of in vitro fertilisation treatment.

S Brett1, P Y Yong, K J Thong.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11495415      PMCID: PMC3455846          DOI: 10.1023/a:1016680504614

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


× No keyword cloud information.
  15 in total

1.  Two rare events in one patient undergoing assisted conception: empty follicle syndrome and ovarian hyperstimulation with the sole administration of a gonadotropin-releasing hormone agonist.

Authors:  Y Khalaf; H Anderson; A Taylor; P Braude
Journal:  Fertil Steril       Date:  2000-01       Impact factor: 7.329

2.  Paradoxical ovarian stimulations in the use of LHRH analogs.

Authors:  J Parinaud; P Oustry; I Bussenot; A Tourre; M Perineau; M Plantavid; X Monrozies; J M Reme; G Pontonnier
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1992-09-23       Impact factor: 2.435

3.  'Curing' empty follicle syndrome.

Authors:  G Ndukwe; S Thornton; S Fishel; K Dowell; M Aloum; S Green
Journal:  Hum Reprod       Date:  1997-01       Impact factor: 6.918

4.  Baseline cyst formation after luteal phase gonadotropin-releasing hormone agonist administration is linked to poor in vitro fertilization outcome.

Authors:  M D Keltz; E E Jones; A J Duleba; T Polcz; K Kennedy; D L Olive
Journal:  Fertil Steril       Date:  1995-09       Impact factor: 7.329

5.  Ovarian hyperstimulation associated with the sole use of leuprolide for ovarian suppression.

Authors:  J Yeh; R L Barbieri; V A Ravnikar
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-08

Review 6.  Ovarian stimulation for in-vitro fertilization/intracytoplasmic sperm injection with gonadotrophins and gonadotrophin-releasing hormone analogues: agonists and antagonists.

Authors:  R Felberbaum; K Diedrich
Journal:  Hum Reprod       Date:  1999-09       Impact factor: 6.918

7.  The empty follicle syndrome: a pharmaceutical industry syndrome.

Authors:  F Zegers-Hochschild; E Fernández; A Mackenna; C Fabres; E Altieri; T Lopez
Journal:  Hum Reprod       Date:  1995-09       Impact factor: 6.918

8.  Empty follicle syndrome.

Authors:  C B Coulam; M Bustillo; J D Schulman
Journal:  Fertil Steril       Date:  1986-12       Impact factor: 7.329

9.  Development of ovarian cysts during gonadotrophin-releasing hormone agonists (GnRHa) administration.

Authors:  M Sampaio; V Serra; F Miro; C Calatayud; R M Castellvi; A Pellicer
Journal:  Hum Reprod       Date:  1991-02       Impact factor: 6.918

10.  Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy.

Authors:  D Feldberg; J Ashkenazi; D Dicker; A Yeshaya; G A Goldman; D Dicker; J A Goldman
Journal:  Fertil Steril       Date:  1989-01       Impact factor: 7.329

View more
  1 in total

1.  Severe ovarian hyperstimulation syndrome associated with long-acting GnRH agonist in oncofertility patients.

Authors:  Jacob Christ; Christopher N Herndon; Bo Yu
Journal:  J Assist Reprod Genet       Date:  2021-01-20       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.